Particle Data Platform

Ozempic Skeptic Meets Defender

14:3314:43 · 10s

Maher admits long-standing doubts about GLP-1 drugs; Swisher pushes back, citing actual scientists and fresh reporting, setting up a timely debate.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.